HIV-1在遗传多样性、耐药性、对抗逆转录病毒的反应、疾病进展以及作为治疗性疫苗开发潜在靶点的体内HIV控制中的作用(第十七部分)

Dr. Zelalem Kiros Bitsue
{"title":"HIV-1在遗传多样性、耐药性、对抗逆转录病毒的反应、疾病进展以及作为治疗性疫苗开发潜在靶点的体内HIV控制中的作用(第十七部分)","authors":"Dr. Zelalem Kiros Bitsue","doi":"10.14299/ijser.2021.11.03","DOIUrl":null,"url":null,"abstract":"Current treatment of HIV/AIDS consists of a combination of three to five agents targeting different viral proteins, i.e. the reverse transcriptase, protease, integrase and envelope, and aims to suppress viral replication below detectable levels.","PeriodicalId":14354,"journal":{"name":"International journal of scientific and engineering research","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The role of HIV-1 on genetic diversity, drug resistance, response to anti-retroviral, disease progression, and on In vivo HIV control as potential target for therapeutic vaccines Development (Part Seventeen)\",\"authors\":\"Dr. Zelalem Kiros Bitsue\",\"doi\":\"10.14299/ijser.2021.11.03\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Current treatment of HIV/AIDS consists of a combination of three to five agents targeting different viral proteins, i.e. the reverse transcriptase, protease, integrase and envelope, and aims to suppress viral replication below detectable levels.\",\"PeriodicalId\":14354,\"journal\":{\"name\":\"International journal of scientific and engineering research\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of scientific and engineering research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14299/ijser.2021.11.03\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of scientific and engineering research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14299/ijser.2021.11.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目前的艾滋病毒/艾滋病治疗包括针对不同病毒蛋白的三到五种药物的组合,即逆转录酶、蛋白酶、整合酶和包膜,目的是将病毒复制抑制在可检测水平以下。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The role of HIV-1 on genetic diversity, drug resistance, response to anti-retroviral, disease progression, and on In vivo HIV control as potential target for therapeutic vaccines Development (Part Seventeen)
Current treatment of HIV/AIDS consists of a combination of three to five agents targeting different viral proteins, i.e. the reverse transcriptase, protease, integrase and envelope, and aims to suppress viral replication below detectable levels.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信